Drug Processing Technology News Today

CMO Dr Jane Robertson shares a sneak peek into trial designs for assets in IPF and Crohn’s disease planned for 2023/2024.

According to the Alzheimer’s association, in 2022 approximately 6.5 million Americans are living with Alzheimer’s disease.

CNS Pharmaceuticals has dosed the first subject in France in the trial analysing Berubicin to treat recurrent glioblastoma multiforme.

Chronic obstructive pulmonary disease is a group of progressive chronic inflammatory lung conditions that cause breathing difficulties.

We analyse the impact of the war on the clinical trial landscapes of Ukraine and Russia, as investigators chronicle the situation on the ground.

Iran’s dominance in women’s health is spread comprehensively across indications, with more clinical trials than any other country.

Concern over the monkeypox virus is higher among men who have sex with men (MSM) due to the nature of monkeypox transmission.

Alzheimer's disease is a progressive neurological disorder that causes brain atrophy and causes brain cells to die.

Care Access has acquired IBPClin, a trial centre in Brazil, to expand its decentralised clinical trial (DCT) capabilities to Latin America.

Four clinical trials in Parkinson’s disease with readouts 2H 2022 target motor symptom fluctuations and cognitive impairment.